News

Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at hscora@ouhsc.edu so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

ORA Research News - Monday, May 24, 2021

PLEASE NOTE: Change to OUHSC new NIH Other Support pages requirements.  OUHSC will not start implementing  this policy internally until October 01, 2021 (previously July 1, 2021).  Please keep in mind, that other institutions  may have already implemented this policy and you may be required to use the new format for them before the OUHSC October 01, 2021 date.

 

Effective immediately, all Human Subject Research (HSR) activities including clinical trials are allowed to resume  provided all OUHSC COVID-19 safety protocols can be met.  It is expected that all personnel will adhere to the requirements in the OUHSC COVID-19 Response Plan.  If your current HSR protocol was temporarily halted due to the COVID-19 restrictions, the HRPP Office will update the study status of those protocols without any action required from you.

Also, in accordance with campus policy, our research laboratories* remain closed to K-12 students for shadowing, volunteer, and educational purposes, but open to visitors, undergraduates, graduates, and post-docs from any institution for those purposes, provided the following are observed by these individuals.  The manager of the area where these individuals will be is responsible for compliance:

  • individuals will be required to show proof of a negative COVID test (within past 48 hours) or documentation of COVID vaccination, if required based on screening results
  • all individuals will complete the HSC online COVID-19 training module in OnPoint, using their HSC credentials
  • all individuals (including students, faculty, staff, and volunteers) will comply with OU’s COVID-19 vaccine policy:
  • those with patient-facing or research participant-facing responsibilities or who will be in patient care or human research
  • all other individuals will be strongly encouraged to be vaccinated against COVID-19

 *     all individuals will be informed that they must comply with and be given the link to the HSC COVID-19 Response Plan

Rotations in clinical areas on campus and at OUMI are limited to OUHSC students, at least through July 2021.

With these changes, we are retiring the Return to Research Plan and will refer to the OUHSC COVID Response Plan for COVID protocols. 

If you identify a deficiency caused by this action, please email vpr@ouhsc.edu

 

OK-INBRE REQUEST FOR APPLICATIONS FOR RESEARCH PROJECTS

The Oklahoma IDeA Network of Biomedical Research Excellence (OK-INBRE) is requesting applications for research projects from full-time, tenure track faculty (or equivalent) at the University of Oklahoma Health Sciences Center (OUHSC) or the Oklahoma Medical Research Foundation (OMRF). OK-INBRE will fund four Research Project Investigator (RPI) Awards with a start date of November 1, 2021 and an end date of April 30, 2024. Funding for awards is anticipated to be $100,000 in direct costs per year. Applications must align with one of the OK-INBRE research themes of 1) Cancer, 2) Developmental Biology, or 3) Infectious Diseases.  The application deadline is 5pm on August 13, 2021. Please see the attached funding opportunity announcement for details. Information can also be found on the OK-INBRE website at Funding Opportunities for OUHSC and OMRF. Questions regarding this OK-INBRE opportunity can be sent to Dawn Hammon (dawn-hammon@ouhsc.edu) or Darrin Akins (darrin-akins@ouhsc.edu).

 

Office of Technology Commercialization presents the following opportunities for researchers to engage with industry (click here for more information, or email otc@ou.edu or meredith-wilkerson@ouhsc.edu).  

  • Reckitt is seeking to engage with academic partners to 1) develop approaches to enhance oral drug delivery into the pharyngeal, esophageal, or colon; 2) enhance the safety of OTC medications, or 3) develop natural/non-medicated solutions for upper and lower GI conditions, sore throat, cough, cold, flu, and pain.  Submission entails a 1-pg non-confidential summary of technology (deadline 5/27/2021)
  • Pfizer’s Centers for Therapeutic Innovation (https://www.pfizercti.com) is seeking collaborative proposals for developing novel therapeutic targets with application in 1) oncology: tumor targeted, immuno-oncology, cancer vaccines; 2) internal medicine: obesity/cachexia, heart failure, diabetic/CKD, NASH/T2D; 3) inflammation and immunology: rheumatology, gastroenterology, medical derm; or 4) rare disease: cardiology, neuro-musc., metabolic, hematology.  Preference is for novel biological targets supported by in vivo and in vitro models, enabling genetics and mechanistic insights, translational biochemical or cellular assay and biomarkers.  Out of scope: drug repurposing, standalone biomarker assays/platforms, medical devices, cell-based therapies.  
  • Proposal template available upon request (submission deadline 6/18/21).

 

Oklahoma Covid-19 Working Group

Information on research activities in Oklahoma that address the Covid-19 pandemic has been added to the  OCTSI Website (http://octsi.ouhsc.edu/covid-19%20working%20group) A list of investigators in the working group and their planned or ongoing projects are described. A list of funded Covid-19 Seed Projects at OUHSC and OU Norman is also included. To be added to the Oklahoma Covid-19 Working Group or to have your information updated, please contact: Mark L. Lang PhD, Presbyterian Health Foundation Presidential Professor, Department of Microbiology and Immunology, OUHSC ( mark-lang@ouhsc.edu ).

Up to date information on allowable OUHSC research activity in response to COVID-19 can be found at:  

https://research.ouhsc.edu/Resources/COVID-Research-Updates

 

NIH NOTICES

NHLBI Announces Availability of Frequently Asked Questions (FAQs) for RFA-HL-20-006 Limited Competition: Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Independent Clinical Trial Not Allowed) (NOT-HL-21-013)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-21-013.html

Availability of Frequently Asked Questions (FAQs) for RFA-HL-22-007 and RFA-HL-22-008: Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Program (NOT-HL-21-014)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-21-014.html

Notice to Extend the Response Date for NOT-LM-21-005, "Request for Information (RFI): Use of Common Data Elements (CDEs) in NIH-funded Research" (NOT-LM-21-008)
https://grants.nih.gov/grants/guide/notice-files/NOT-LM-21-008.html

Notice of Correction to Award Budget for PA-21-235, "NIMH Exploratory/Developmental Research Grant (R21 Clinical Trial Not Allowed)" (NOT-MH-21-290)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-21-290.html

Request for Information (RFI): Seeking Stakeholder Input on Enhancing Diversity and Inclusion in the Cancer Research Workforce (NOT-CA-21-067)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-21-067.html

Request for Information (RFI): Facilitating the Early Diagnosis and Equitable Delivery of Gene-Targeted Therapies to Individuals with Rare Diseases (NOT-TR-21-027)
https://grants.nih.gov/grants/guide/notice-files/NOT-TR-21-027.html

Notice of Change to Eligibility Information for RFA-AA-20-013 "Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia (U01 Clinical Trial Optional) (NOT-AA-21-030)
https://grants.nih.gov/grants/guide/notice-files/NOT-AA-21-030.html

Notice of NIAAA's participation in NOT-NS-21-049, "Notice of Special Interest (NOSI): NIH Research Project Grant (R01) Applications from Individuals from Diverse Backgrounds, Including Under-Represented Minorities" (NOT-AA-21-031)
https://grants.nih.gov/grants/guide/notice-files/NOT-AA-21-031.html

Notice of NIDCD Withdrawal from Participation in PA-20-184, "Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required) (NOT-DC-21-002)
https://grants.nih.gov/grants/guide/notice-files/NOT-DC-21-002.html

Notice of Correction to the Application and Submission Instructions for the Pilot and Feasibility Program for RFA-DK-21-015, Nutrition Obesity Research Centers (P30 Clinical Trial Optional) (NOT-DK-21-020)
https://grants.nih.gov/grants/guide/notice-files/NOT-DK-21-020.html

Notice of Termination of NIEHS Participation on NOT-EB-21-012, Notice of Extension of the Expiration Date of PAR-19-159,"Bioengineering Research Grants (BRG) (R01 Clinical Trial Required)" (NOT-ES-21-007)
https://grants.nih.gov/grants/guide/notice-files/NOT-ES-21-007.html

Notice of Correction to NOT-OD-21-103, "Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations RADx-UP Phase II (Emergency Supplement – Clinical Trial Optional) (NOT-OD-21-125)
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-125.html

Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed) (NOT-CA-21-079)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-21-079.html

Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Data and Resource Coordination Center (DRCC) (U24 Clinical Trial Not Allowed) (NOT-CA-21-080)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-21-080.html

Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint Medtech: Small Business Translator (U44) (NOT-DA-22-050)
https://grants.nih.gov/grants/guide/notice-files/NOT-DA-22-050.html

Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint MedTech: Prototyper Prototype Developer (U18 Clinical Trial Not Allowed) (NOT-EB-21-018)
https://grants.nih.gov/grants/guide/notice-files/NOT-EB-21-018.html

Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint MedTech: Incubator Hubs (U54 Clinical Trial Not Allowed) (NOT-EB-21-019)
https://grants.nih.gov/grants/guide/notice-files/NOT-EB-21-019.html

Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint MedTech: Translator (UG3/UH3 Clinical Trial Optional) (NOT-NS-21-057)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-21-057.html

Notice of Special Interest (NOSI): Availability of Urgent Award for Competitive Revisions to IDeA-CTR Awards to Address the Continued Need for Documenting COVID-19-Related Patient Outcomes (NOT-GM-21-050)
https://grants.nih.gov/grants/guide/notice-files/NOT-GM-21-050.html

Notice of Special Interest (NOSI): Administrative Supplements to Enhance Data Science Capacity at NIMHD-Funded Research Centers in Minority Institutions (RCMI) (NOT-MD-21-021) 

https://grants.nih.gov/grants/guide/notice-files/NOT-MD-21-021.html

Please Note:  When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted).  The letters of intent will be reviewed and a single application will be chosen for submission from the University.

 

NIH DEADLINES

 

Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional) (PA-21-180) - Deadline June 16, 2021 and October 16, 2021

https://grants.nih.gov/grants/guide/pa-files/PA-21-180.html

Development and Testing of Novel Interventions to improve HIV Prevention, Treatment, and Program Implementation for People Who Use Drugs (R34 Clinical Trial Required) (PA-21-205) – Deadline September 7, 2021 and January 7, 2022

https://grants.nih.gov/grants/guide/pa-files/PA-21-205.html

Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional)
(PA-21-219) – Deadline June 16, 2021 and October 16, 2021

https://grants.nih.gov/grants/guide/pa-files/PA-21-219.html

NIMH Exploratory/Developmental Research Grant (R21 Clinical Trial Not Allowed) (PA-21-235)
Deadline June 16, 2021 and October 16, 2021

https://grants.nih.gov/grants/guide/pa-files/PA-21-235.html

Summer Research Education Experience Program (R25 Clinical Trial Not Allowed) (PAR-21-168)
Deadline March 17, 2022 and March 17, 2023 

https://grants.nih.gov/grants/guide/pa-files/PAR-21-168.html

Emerging Science and Technology in Transplantation (U01 Clinical Trial Not Allowed) (RFA-AI-21-016)
Deadline September 03, 2021

https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-016.html

SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed)
(RFA-ES-21-005) - Deadline July 30, 2021

https://grants.nih.gov/grants/guide/rfa-files/RFA-ES-21-005.html

T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed)
(RFA-HL-22-001) - Deadline September 13, 2021 an February 28, 2022

https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-22-001.html

OTHER FEDERAL DEADLINES

Department of Defense (DOD) – Pancreatic Cancer Research Program (PCARP) – Idea Development Award Required PreApplication due July 01, 2021

https://cdmrp.army.mil/funding/pcarp

DOD – PCARP – Translational Research Partnership Award – Required PreApplication due July 01, 2021

https://cdmrp.army.mil/funding/pcarp

DOD – Vision Research Program (VRP) – Clinical Trial Award – PreApplication due July 21, 2021

https://cdmrp.army.mil/funding/vrp

DOD – VRP – Focused Translational Team Science Award – PreApplication due July 21, 2021

https://cdmrp.army.mil/funding/vrp

DOD – VRP – Investigator Initiated Research Award – PreApplication due July 21, 2021

https://cdmrp.army.mil/funding/vrp

DOD – VRP – Translational Research Award – PreApplication due July 21, 2021

https://cdmrp.army.mil/funding/vrp

DOD – Rare Cancers Research Program (RCRP) – Concept Award – PreApplication due July 13, 2021

https://cdmrp.army.mil/funding/rcrp

DOD – RCRP – Idea Development Award – PreApplication due July 13, 2021

https://cdmrp.army.mil/funding/rcrp

DOD – RCRP – Resource and Community Development Award – PreApplication due July 13, 2021

https://cdmrp.army.mil/funding/rcrp

Print